Delhi High Court Refuses Stay on HPV Vaccination Drive – Legal and Health Policy Implications

The Delhi High Court on 29 July 2026 rejected a petition to halt the central government's ongoing HPV vaccine programme for 14‑year‑old girls. The bench said the material before it did not show any immediate harm and that the vaccine is not part of the Universal Immunisation Programme. Key Developments The bench comprising Chief Justice D.K. Upadhyaya and Justice Tejas Karia observed that the data on 5.5 million doses administered showed no "instant harm". The court warned against "half‑baked vaccines" and stressed strict adherence to protocols. It directed the Centre, the CDSCO and the ICMR to file separate replies within four weeks. The petition, filed as a PIL , raised concerns over long‑term safety, informed consent and adverse‑event monitoring. Important Facts According to the Additional Solicitor General Chetan Sharma, as of 25 July 2026, 5.5 million doses had been given, with 120 adverse‑event reports. Of these, 42 were "slightly aggravated" symptoms and no deaths were recorded. The programme, launched on 28 February 2026, is voluntary and requires prior informed consent from parents. The petitioners cited international safety concerns about the brand Gardasil and a specific case from Tamil Nadu where a girl reportedly developed severe neurological symptoms within days of vaccination. UPSC Relevance This case touches upon several GS topics: public health policy (preventive vaccination, consent norms), administrative law (role of courts in reviewing executive actions), and regulatory oversight (functions of CDSCO and ICMR ). Understanding the balance between rapid public‑health interventions and safety monitoring is crucial for questions on health governance and judicial review. Way Forward The court will examine the detailed replies from the Centre, CDSCO and ICMR at the next hearing scheduled for 29 October 2026. Continued surveillance of adverse events, transparent communication of risk‑benefit data, and strict adherence to informed‑consent procedures will be essential to sustain public confidence and meet constitutional health obligations.